KEGG   Lutra lutra (Eurasian river otter): 125091274
Entry
125091274         CDS       T08100                                 
Name
(RefSeq) caspase-3
  KO
K02187  caspase 3 [EC:3.4.22.56]
Organism
llv  Lutra lutra (Eurasian river otter)
Pathway
llv01524  Platinum drug resistance
llv04010  MAPK signaling pathway
llv04115  p53 signaling pathway
llv04148  Efferocytosis
llv04210  Apoptosis
llv04215  Apoptosis - multiple species
llv04623  Cytosolic DNA-sensing pathway
llv04650  Natural killer cell mediated cytotoxicity
llv04657  IL-17 signaling pathway
llv04668  TNF signaling pathway
llv04726  Serotonergic synapse
llv04932  Non-alcoholic fatty liver disease
llv04933  AGE-RAGE signaling pathway in diabetic complications
llv04936  Alcoholic liver disease
llv05010  Alzheimer disease
llv05012  Parkinson disease
llv05014  Amyotrophic lateral sclerosis
llv05016  Huntington disease
llv05020  Prion disease
llv05022  Pathways of neurodegeneration - multiple diseases
llv05132  Salmonella infection
llv05133  Pertussis
llv05134  Legionellosis
llv05145  Toxoplasmosis
llv05146  Amoebiasis
llv05152  Tuberculosis
llv05160  Hepatitis C
llv05161  Hepatitis B
llv05162  Measles
llv05163  Human cytomegalovirus infection
llv05164  Influenza A
llv05165  Human papillomavirus infection
llv05167  Kaposi sarcoma-associated herpesvirus infection
llv05168  Herpes simplex virus 1 infection
llv05169  Epstein-Barr virus infection
llv05170  Human immunodeficiency virus 1 infection
llv05200  Pathways in cancer
llv05203  Viral carcinogenesis
llv05205  Proteoglycans in cancer
llv05206  MicroRNAs in cancer
llv05210  Colorectal cancer
llv05222  Small cell lung cancer
llv05416  Viral myocarditis
llv05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:llv00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    125091274
   04668 TNF signaling pathway
    125091274
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    125091274
  09143 Cell growth and death
   04210 Apoptosis
    125091274
   04215 Apoptosis - multiple species
    125091274
   04115 p53 signaling pathway
    125091274
 09150 Organismal Systems
  09151 Immune system
   04623 Cytosolic DNA-sensing pathway
    125091274
   04650 Natural killer cell mediated cytotoxicity
    125091274
   04657 IL-17 signaling pathway
    125091274
  09156 Nervous system
   04726 Serotonergic synapse
    125091274
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    125091274
   05206 MicroRNAs in cancer
    125091274
   05205 Proteoglycans in cancer
    125091274
   05203 Viral carcinogenesis
    125091274
  09162 Cancer: specific types
   05210 Colorectal cancer
    125091274
   05222 Small cell lung cancer
    125091274
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    125091274
   05161 Hepatitis B
    125091274
   05160 Hepatitis C
    125091274
   05164 Influenza A
    125091274
   05162 Measles
    125091274
   05168 Herpes simplex virus 1 infection
    125091274
   05163 Human cytomegalovirus infection
    125091274
   05167 Kaposi sarcoma-associated herpesvirus infection
    125091274
   05169 Epstein-Barr virus infection
    125091274
   05165 Human papillomavirus infection
    125091274
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    125091274
   05133 Pertussis
    125091274
   05134 Legionellosis
    125091274
   05152 Tuberculosis
    125091274
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    125091274
   05145 Toxoplasmosis
    125091274
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    125091274
   05012 Parkinson disease
    125091274
   05014 Amyotrophic lateral sclerosis
    125091274
   05016 Huntington disease
    125091274
   05020 Prion disease
    125091274
   05022 Pathways of neurodegeneration - multiple diseases
    125091274
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    125091274
   05416 Viral myocarditis
    125091274
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    125091274
   04932 Non-alcoholic fatty liver disease
    125091274
   04933 AGE-RAGE signaling pathway in diabetic complications
    125091274
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    125091274
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01002 Peptidases and inhibitors [BR:llv01002]
    125091274
Enzymes [BR:llv01000]
 3. Hydrolases
  3.4  Acting on peptide bonds (peptidases)
   3.4.22  Cysteine endopeptidases
    3.4.22.56  caspase-3
     125091274
Peptidases and inhibitors [BR:llv01002]
 Cysteine peptidases
  Family C14: caspase family
   125091274
SSDB
Motif
Pfam: Peptidase_C14 SICA_beta
Other DBs
NCBI-GeneID: 125091274
NCBI-ProteinID: XP_047570680
LinkDB
Position
2:complement(15545832..15567888)
AA seq 277 aa
MENSEHSVDAKSIKNSETKILHGSKSVDSGMSLDNSYKMDYPEMGLCIIINNKNFHRSTG
MAPRSGTDVDAANLRETFTNLKYEVRNKNDLTCEEILELMDSVSKEDHSKRSSFVCVLLS
HGDEGIIFGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTDLDCGIETDSGAED
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCTMLKLYAHKLEFMHILTRVN
RKVATEFESFSLDSAFHGKKQIPCIVSMLTKELYLYH
NT seq 834 nt   +upstreamnt  +downstreamnt
atggagaacagtgaacactccgtggacgcaaaatccattaaaaattcagaaacaaagatc
ttacatggaagcaaatcagtggactctggaatgtccttggacaacagttataaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcatagaagtactgga
atggcacctcggtctggtacagatgtagatgcagcaaacctccgggaaacattcacaaac
ttgaaatatgaagtcaggaataaaaatgatctcacatgcgaagaaattttggaattaatg
gacagtgtctctaaagaagatcatagcaaaaggagcagttttgtttgtgtacttctaagc
catggggatgaaggaataatttttggaaccaatggacctgttgacctgaaaaaactaaca
ggtttcttcagaggggattactgtcgaagtctgactggaaaacccaaacttttcattatt
caggcctgccgaggcacagacctggactgcggtattgagacggacagtggagctgaggac
gacatggcctgtcagaaaataccagttgaagcggacttcctgtatgcctattccacggcc
cctggttactattcctggcgaaactcaaaggacggatcctggttcatccagtcactctgc
acgatgctgaaactgtatgctcacaagcttgagtttatgcacattcttacccgagttaac
cgaaaggtagccacagaatttgagtccttttctcttgactctgcttttcatggaaagaaa
cagattccatgtattgtgtctatgctcacaaaagaactgtatctttatcactaa

DBGET integrated database retrieval system